Kazia Therapeutics KZIA Stock
Kazia Therapeutics Price Chart
Kazia Therapeutics KZIA Financial and Trading Overview
| Kazia Therapeutics stock price | 3.56 USD |
| Previous Close | 1.26 USD |
| Open | 1.24 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1400 |
| Day's Range | 1.24 - 1.26 USD |
| 52 Week Range | 0.5 - 6.38 USD |
| Volume | 7.54K USD |
| Avg. Volume | 31.53K USD |
| Market Cap | 25.75M USD |
| Beta (5Y Monthly) | 2.269731 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -32.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.04 USD |
KZIA Valuation Measures
| Enterprise Value | 16.75M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | 1.774648 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.725 |
Trading Information
Kazia Therapeutics Stock Price History
| Beta (5Y Monthly) | 2.269731 |
| 52-Week Change | -76.091% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.38 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 1.28 USD |
| 200-Day Moving Average | 1.02 USD |
KZIA Share Statistics
| Avg. Volume (3 month) | 31.53K USD |
| Avg. Daily Volume (10-Days) | 11.41K USD |
| Shares Outstanding | 20.43M |
| Float | 11.38M |
| Short Ratio | 8.71 |
| % Held by Insiders | 0% |
| % Held by Institutions | 1.89% |
| Shares Short | 161.45K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.19% |
| Return on Equity (ttm) | -135.030% |
Income Statement
| Revenue (ttm) | 0 USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -99.70% |
| Gross Profit (ttm) | 10K USD |
| EBITDA | -23103516 USD |
| Net Income Avi to Common (ttm) | -25031994 USD |
| Diluted EPS (ttm) | -1.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.39M USD |
| Total Cash Per Share (mrq) | 0.27 USD |
| Total Debt (mrq) | 552.32K USD |
| Total Debt/Equity (mrq) | 4.77 USD |
| Current Ratio (mrq) | 1.06 |
| Book Value Per Share (mrq) | 0.71 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20177400 USD |
| Levered Free Cash Flow (ttm) | -14297770 USD |
Profile of Kazia Therapeutics
| Country | United States |
| State | NSW |
| City | Sydney |
| Address | Three International Towers |
| ZIP | 2000 |
| Phone | N/A |
| Website | https://www.kaziatherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.
Q&A For Kazia Therapeutics Stock
What is a current KZIA stock price?
Kazia Therapeutics KZIA stock price today per share is 3.56 USD.
How to purchase Kazia Therapeutics stock?
You can buy KZIA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kazia Therapeutics?
The stock symbol or ticker of Kazia Therapeutics is KZIA.
Which industry does the Kazia Therapeutics company belong to?
The Kazia Therapeutics industry is Biotechnology.
How many shares does Kazia Therapeutics have in circulation?
The max supply of Kazia Therapeutics shares is 1.12M.
What is Kazia Therapeutics Price to Earnings Ratio (PE Ratio)?
Kazia Therapeutics PE Ratio is now.
What was Kazia Therapeutics earnings per share over the trailing 12 months (TTM)?
Kazia Therapeutics EPS is -32.33 USD over the trailing 12 months.
Which sector does the Kazia Therapeutics company belong to?
The Kazia Therapeutics sector is Healthcare.
Kazia Therapeutics KZIA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Capital Market Composite RCMP | 102.11 USD — |
-0.04
|
— — | 100.72 USD — | 103.65 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}